Systemic vasculitides are heterogeneous disabling diseases characterised by chronic
inflammation of the blood vessels potentially leading to tissue destruction and organ failure …

The recent publication of the American College of Rheumatology (ACR)-European Alliance
of Associations for Rheumatology (EULAR) classification criteria for large vessel vasculitis …

Objective To examine the performance of the new 2022 American College of Rheumatology
(ACR)/EULAR giant cell arteritis (GCA) classification criteria for diagnosis in routine clinical …

Background To examine the performance of the new 2022 American College of
Rheumatology (ACR)/EULAR classification criteria for giant cell arteritis (GCA) in routine …

Rheumatologists are increasingly using vascular ultrasound. Several guidelines now
recommend ultrasound as the first diagnostic modality in giant cell arteritis (GCA). The …

Systemic vasculitides comprise a group of autoimmune diseases affecting blood vessels,
including large vessel vasculitis (LVV) and medium-sized vessel vasculitis such as giant cell …

Objectives To investigate the clinicopathologic features of patients with giant cell arteritis
(GCA) who had thoracic aorta aneurysm or dissection surgery. Methods Patients who had …

Objective To evaluate the safety and efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA)
in a large North American cohort. Methods Patients with GCA treated with TCZ between …

Objective To identify the key coding genes underlying the biomarkers and pathways
associated with giant cell arteritis (GCA), we performed an in situ spatial profiling of …

Objectives To investigate the diagnostic performance of diffusion-weighted imaging (DWI) of
the superficial cranial arteries in the diagnosis of GCA. Methods Retrospectively, 156 …